Back to Search
NIRMALA SHEVDE, M.D.
M.D.
Specialist
NPI: 1740365832IndividualAccepts Medicare
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
127252(NY)
Education
OTHER
Class of 1971
Research & Publications (20)
Comparative chondrogenesis of human cell sources in 3D scaffolds.
PMID 19382119·J Tissue Eng Regen Med·2009
8-other
Vitamin D-binding protein influences total circulating levels of 1,25-dihydroxyvitamin D3 but does not directly modulate the bioactive levels of the hormone in vivo.
PMID 18372326·Endocrinology·2008
7-preclinical
Receptor activator of nuclear factor-kappaB ligand-induced nuclear factor of activated T cells (C1) autoregulates its own expression in osteoclasts and mediates the up-regulation of tartrate-resistant acid phosphatase.
PMID 18063694·Mol Endocrinol·2008
7-preclinical
1,25-Dihydroxyvitamin D3 induces expression of the Wnt signaling co-regulator LRP5 via regulatory elements located significantly downstream of the gene's transcriptional start site.
PMID 17229572·J Steroid Biochem Mol Biol·2007
7-preclinical
Perspectives on mechanisms of gene regulation by 1,25-dihydroxyvitamin D3 and its receptor.
PMID 17223545·J Steroid Biochem Mol Biol·2007
7-preclinical
Enhancers located in the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3.
PMID 17218097·J Steroid Biochem Mol Biol·2007
7-preclinical
Multiple enhancer regions located at significant distances upstream of the transcriptional start site mediate RANKL gene expression in response to 1,25-dihydroxyvitamin D3.
PMID 17197168·J Steroid Biochem Mol Biol·2007
7-preclinical
Transcriptional control of receptor activator of nuclear factor-kappaB ligand by the protein kinase A activator forskolin and the transmembrane glycoprotein 130-activating cytokine, oncostatin M, is exerted through multiple distal enhancers.
PMID 17053039·Mol Endocrinol·2007
7-preclinical
Activation of receptor activator of NF-kappaB ligand gene expression by 1,25-dihydroxyvitamin D3 is mediated through multiple long-range enhancers.
PMID 16914732·Mol Cell Biol·2006
7-preclinical
1,25-Dihydroxyvitamin D3 regulates the expression of low-density lipoprotein receptor-related protein 5 via deoxyribonucleic acid sequence elements located downstream of the start site of transcription.
PMID 16613987·Mol Endocrinol·2006
7-preclinical
The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in intestinal cells.
PMID 16574738·Mol Endocrinol·2006
8-other
Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3.
PMID 16497728·Mol Endocrinol·2006
7-preclinical
1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
PMID 15647825·J Bone Miner Res·2005
7-preclinical
2-Methylene-19-nor-(20S)-1,25-dihydroxyvitamin D3 potently stimulates gene-specific DNA binding of the vitamin D receptor in osteoblasts.
PMID 12796488·J Biol Chem·2003
7-preclinical
Synthetic LXXLL peptide antagonize 1,25-dihydroxyvitamin D3-dependent transcription.
PMID 12520523·J Cell Biochem·2003
7-preclinical
Inhibition of 1,25-dihydroxyvitamin D3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptors.
PMID 12469913·J Bone Miner Res·2002
7-preclinical
A potent analog of 1alpha,25-dihydroxyvitamin D3 selectively induces bone formation.
PMID 12374862·Proc Natl Acad Sci U S A·2002
7-preclinical
Vitamin D receptor-mediated gene regulation mechanisms and current concepts of vitamin D analog selectivity.
PMID 12203198·Adv Ren Replace Ther·2002
6-review
Enhanced activity of osteoblast differentiation factor (PEBP2alphaA2/CBFa1) in affected sutural osteoblasts from patients with nonsyndromic craniosynostosis.
PMID 11681994·Cleft Palate Craniofac J·2001
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3003 NEW HYDE PARK RD, STE 401
NEW HYDE PARK, NY 11042 - Phone
- (516) 354-5700
Quick Facts
- NPI
- 1740365832
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 55
- Publications
- 20
Are you this provider?
Claim Your Profile